Sort
30,917 grants matching “tumor microenvironment”
UCLA SPORE in Brain Cancer
$2,300,000Linda M Liau · University Of California Los Angeles · P50 · FY2018 · CA
UCLA SPORE in Prostate Cancer
$2,300,000Robert E Reiter · University Of California Los Angeles · P50 · FY2017 · CA
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
$2,300,000Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Mayo Clinic SPORE in Ovarian Cancer
$2,300,000Lynn C. Hartmann · Mayo Clinic Rochester · P50 · FY2010 · CA
University of Texas SPORE in Lung Cancer
$2,300,000John D Minna · Ut Southwestern Medical Center · P50 · FY2008 · CA
University of Texas SPORE in Lung Cancer
$2,300,000John D Minna · Ut Southwestern Medical Center · P50 · FY2012 · CA
SPORE in Lymphoma
$2,300,000Helen E Heslop · Baylor College Of Medicine · P50 · FY2012 · CA
University of Texas SPORE in Lung Cancer
$2,300,000John D Minna · Ut Southwestern Medical Center · P50 · FY2009 · CA
University of Texas SPORE in Lung Cancer
$2,300,000John D Minna · Ut Southwestern Medical Center · P50 · FY2010 · CA
Mayo Clinic SPORE in Ovarian Cancer
$2,300,000Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2012 · CA
SPORE: Targeted Therapies for Glioma
$2,298,683Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2020 · CA
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,298,345George J Weiner · University Of Iowa · P50 · FY2021 · CA
SPORE in Lymphoma
$2,297,796Helen E Heslop · Baylor College Of Medicine · P50 · FY2018 · CA
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,296,936Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation
$2,295,320Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mayo Clinic Hepatobiliary SPORE
$2,286,710Mark A. Mc Niven · Mayo Clinic Rochester · P50 · FY2025 · CA
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,281,096Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2024 · CA
Molecular mechanisms of membrane remodeling
$2,279,469Roberto Weigert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
COBRE Center for Cancer Research Development
$2,274,718Douglas C Hixson · Rhode Island Hospital · P20 · FY2010 · RR
INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS
$2,273,048Massachusetts General Hospital · P01 · FY2002 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$2,272,641Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2021 · CA
Sex, Chromosomes, and Immunity in Bladder Cancer
$2,272,271Xue Sean Li · Cedars-Sinai Medical Center · P01 · FY2023 · CA
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
$2,270,520Cassian Yee · University Of Tx Md Anderson Can Ctr · UH3 · FY2025 · CA
Interrogating the molecular underpinnings of metastatic colonization
$2,269,360Jonathan Hernandez · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
SPORE in Lymphoma
$2,266,618Helen E Heslop · Baylor College Of Medicine · P50 · FY2007 · CA